New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells-Reference-Cited by-同舟云学术

New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells

Published:2022-10-21 Issue:21 Volume:65 Page:14655-14672
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Braconi Laura¹,Teodori Elisabetta¹^ORCID,Riganti Chiara²^ORCID,Coronnello Marcella³,Nocentini Alessio¹^ORCID,Bartolucci Gianluca¹^ORCID,Pallecchi Marco¹,Contino Marialessandra⁴^ORCID,Manetti Dina¹^ORCID,Romanelli Maria Novella¹^ORCID,Supuran Claudiu T.¹^ORCID,Dei Silvia¹^ORCID

Affiliation:

1. Department of Neuroscience, Psychology, Drug Research and Child Health - Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, via Ugo Schiff 6, 50019Sesto Fiorentino (FI), Italy

2. Department of Oncology, University of Turin, Via Santena 5/bis, 10126Torino, Italy

3. Department of Health Sciences - Clinical Pharmacology and Oncology Section, University of Florence, Viale Pieraccini 6, 50139Firenze, Italy

4. Department of Pharmacy - Drug Sciences, University of Bari “A. Moro”, via Orabona 4, 70125Bari, Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Universit? degli Studi di Firenze

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c01175